P

Pharmaniaga Bhd
KLSE:PHARMA

Watchlist Manager
Pharmaniaga Bhd
KLSE:PHARMA
Watchlist
Price: 0.345 MYR 1.47% Market Closed
Market Cap: 497.2m MYR
Have any thoughts about
Pharmaniaga Bhd?
Write Note

Intrinsic Value

PHARMA's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one PHARMA stock under the Base Case scenario is 1.101 MYR. Compared to the current market price of 0.345 MYR, Pharmaniaga Bhd is Undervalued by 69%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

PHARMA Intrinsic Value
1.101 MYR
Undervaluation 69%
Intrinsic Value
Price
P
Worst Case
Base Case
Best Case

Valuation History
Pharmaniaga Bhd

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
PHARMA
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for PHARMA cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about PHARMA?
Bearish
Neutral
Bullish

Fundamental Analysis

0.345 MYR
+1.47%
+1.47%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Pharmaniaga Bhd
MY
Health Care
Market Cap
497.2m MYR
IPO
Nov 12, 1999
Employees
3 642
Malaysia
Market Cap
497.2m MYR
Industry
Health Care
IPO
Nov 12, 1999
Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Pharmaniaga Bhd

Provide an overview of the primary business activities
of Pharmaniaga Bhd.

What unique competitive advantages
does Pharmaniaga Bhd hold over its rivals?

What risks and challenges
does Pharmaniaga Bhd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Pharmaniaga Bhd.

Provide P/S
for Pharmaniaga Bhd.

Provide P/E
for Pharmaniaga Bhd.

Provide P/OCF
for Pharmaniaga Bhd.

Provide P/FCFE
for Pharmaniaga Bhd.

Provide P/B
for Pharmaniaga Bhd.

Provide EV/S
for Pharmaniaga Bhd.

Provide EV/GP
for Pharmaniaga Bhd.

Provide EV/EBITDA
for Pharmaniaga Bhd.

Provide EV/EBIT
for Pharmaniaga Bhd.

Provide EV/OCF
for Pharmaniaga Bhd.

Provide EV/FCFF
for Pharmaniaga Bhd.

Provide EV/IC
for Pharmaniaga Bhd.

Show me price targets
for Pharmaniaga Bhd made by professional analysts.

What are the Revenue projections
for Pharmaniaga Bhd?

How accurate were the past Revenue estimates
for Pharmaniaga Bhd?

What are the Net Income projections
for Pharmaniaga Bhd?

How accurate were the past Net Income estimates
for Pharmaniaga Bhd?

What are the EPS projections
for Pharmaniaga Bhd?

How accurate were the past EPS estimates
for Pharmaniaga Bhd?

What are the EBIT projections
for Pharmaniaga Bhd?

How accurate were the past EBIT estimates
for Pharmaniaga Bhd?

Compare the revenue forecasts
for Pharmaniaga Bhd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Pharmaniaga Bhd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Pharmaniaga Bhd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Pharmaniaga Bhd compared to its peers.

Compare the P/E ratios
of Pharmaniaga Bhd against its peers.

Discuss the investment returns and shareholder value creation
comparing Pharmaniaga Bhd with its peers.

Analyze the financial leverage
of Pharmaniaga Bhd compared to its main competitors.

Show all profitability ratios
for Pharmaniaga Bhd.

Provide ROE
for Pharmaniaga Bhd.

Provide ROA
for Pharmaniaga Bhd.

Provide ROIC
for Pharmaniaga Bhd.

Provide ROCE
for Pharmaniaga Bhd.

Provide Gross Margin
for Pharmaniaga Bhd.

Provide Operating Margin
for Pharmaniaga Bhd.

Provide Net Margin
for Pharmaniaga Bhd.

Provide FCF Margin
for Pharmaniaga Bhd.

Show all solvency ratios
for Pharmaniaga Bhd.

Provide D/E Ratio
for Pharmaniaga Bhd.

Provide D/A Ratio
for Pharmaniaga Bhd.

Provide Interest Coverage Ratio
for Pharmaniaga Bhd.

Provide Altman Z-Score Ratio
for Pharmaniaga Bhd.

Provide Quick Ratio
for Pharmaniaga Bhd.

Provide Current Ratio
for Pharmaniaga Bhd.

Provide Cash Ratio
for Pharmaniaga Bhd.

What is the historical Revenue growth
over the last 5 years for Pharmaniaga Bhd?

What is the historical Net Income growth
over the last 5 years for Pharmaniaga Bhd?

What is the current Free Cash Flow
of Pharmaniaga Bhd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Pharmaniaga Bhd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Pharmaniaga Bhd

Current Assets 1.3B
Cash & Short-Term Investments 66.4m
Receivables 654.1m
Other Current Assets 620.3m
Non-Current Assets 805.4m
PP&E 603.6m
Intangibles 150.1m
Other Non-Current Assets 51.6m
Current Liabilities 2.1B
Accounts Payable 925m
Other Current Liabilities 1.2B
Non-Current Liabilities 183m
Long-Term Debt 113.6m
Other Non-Current Liabilities 69.5m
Efficiency

Earnings Waterfall
Pharmaniaga Bhd

Revenue
3.6B MYR
Cost of Revenue
-3.2B MYR
Gross Profit
440.8m MYR
Operating Expenses
-440.8m MYR
Operating Income
0 MYR
Other Expenses
94m MYR
Net Income
94m MYR
Fundamental Scores

PHARMA Profitability Score
Profitability Due Diligence

Pharmaniaga Bhd's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

Positive 1-Year Revenue Growth
Positive Gross Profit
Negative Free Cash Flow
Low ROIC
29/100
Profitability
Score

Pharmaniaga Bhd's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

PHARMA Solvency Score
Solvency Due Diligence

Pharmaniaga Bhd's solvency score is 49/100. The higher the solvency score, the more solvent the company is.

Low D/E
Positive Net Debt
Long-Term Solvency
Short-Term Solvency
49/100
Solvency
Score

Pharmaniaga Bhd's solvency score is 49/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PHARMA Price Targets Summary
Pharmaniaga Bhd

Wall Street analysts forecast PHARMA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PHARMA is 0.398 MYR with a low forecast of 0.394 MYR and a high forecast of 0.41 MYR.

Lowest
Price Target
0.394 MYR
14% Upside
Average
Price Target
0.398 MYR
15% Upside
Highest
Price Target
0.41 MYR
19% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for PHARMA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one PHARMA stock?

The intrinsic value of one PHARMA stock under the Base Case scenario is 1.101 MYR.

Is PHARMA stock undervalued or overvalued?

Compared to the current market price of 0.345 MYR, Pharmaniaga Bhd is Undervalued by 69%.

Back to Top